Skip to content

Resolvin D1 Levels in Patients With Periodontitis

The Role of Resolvin D1 in Maintaining Oral Health

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04496570
Enrollment
26
Registered
2020-08-03
Start date
2019-07-31
Completion date
2020-02-29
Last updated
2020-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis

Keywords

gingival crevicular fluid, resolvin D1

Brief summary

The purpose of the study was to determine the levels of Resolvin D1 (RVD1) in the gingival crevicular fluid (GCF) and saliva of the patients with periodontitis (P) and also to investigate the effects of non-surgical periodontal treatments (NSPTs) on its levels. A total of 26 subjects (15 P, 11 healthy) were included. Clinical periodontal measurements, GCF and saliva samples were collected from each individual at baseline and 1 month after NSPTs in P group. RVD1 levels were determined by enzyme-linked immunosorbent assay (ELISA) method.

Interventions

Non surgical periodontal therapy was performed to patients with peridontitis

Sponsors

Ordu University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Stage 3, Grade B and generalized periodontitis patients

Exclusion criteria

* excessive forces; * presence of systemic diseases * administration of non-steroidal and anti-inflammatory drugs or antibiotic therapies within the previous 6 months * having received non-surgical periodontal treatment within the past 6 months * allergy or sensitivity to any drug, * pregnancy, lactation * current and former use of tobacco.

Design outcomes

Primary

MeasureTime frameDescription
Biochemical parameter (resolvin D1)Baseline and 1 month after NSPTThe changes in levels of resolvin D1 after periodontal treatment determined by ELISA.

Secondary

MeasureTime frameDescription
Probing pocket depthBaseline and 1 month after NSPTThe changes in probing pocket depth after periodontal treatment were evaluated
Clinical attachment level (CAL)Baseline and 1 month after NSPTThe changes in CAL after periodontal treatment were evaluated
Plaque index (PI)Baseline and 1 month after NSPTThe changes in PI after periodontal treatment were evaluated
Gingival index (GI)Baseline and 1 month after NSPTThe changes in GI after periodontal treatment were evaluated

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026